Thomas Miller/Linkedin
Jun 16, 2025, 15:00
Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA 2025
Thomas Miller, Principal Investigator at Institut Paoli-Calmettes, shared a post on LinkedIn:
“Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025
Excellent final day at EHA2025. Institut Paoli-Calmettes was particularly engaged by the dedicated session on BCL-2 inhibitor therapies, highlighted by Sylvain Garciaz’s insightful presentation on inherent and acquired resistance mechanisms.
This critical discussion sparks a vital question: How can we develop smarter strategies to utilize BCL-2 inhibitors, circumvent multi-drug resistance, and unlock new combination opportunities, especially for the elderly patient population?
At Institut Paoli-Calmettes, we are committed to exploring these avenues, pushing the boundaries of research to enhance treatment efficacy and improve patient outcomes.
Let’s continue this crucial conversation and collaborate on innovative solutions!”
Find more posts featuring EHA 2025.
-
Jun 19, 2025, 03:39ASH Recognizes 11 Hematologists for Transformative Contributions to Blood Disorder Research
-
Jun 17, 2025, 10:3025 Posts Not to Miss from EHA 2025
-
Jun 17, 2025, 05:10Recombinant ADAMTS13 Shows Superior Efficacy Over Plasma in Congenital TTP: A Paradigm Shift in Replacement Therapy - Blood Journals Portfolio
-
Jun 16, 2025, 17:00Hypoxia and Emergency Caesarean Deliveries Worsen Postpartum Outcomes in Sickle Cell Disease: New Insights from Perinatal Hemostasis Research
-
Jun 16, 2025, 10:42Jorge Cortes: The First Issue of Blood Global Hematology is Out
-
Jun 18, 2025, 15:49Abdul Mannan: Laboratory Alert - DOAC Interference in Heparin Monitoring
-
Jun 18, 2025, 08:19William Aird: Thrombocytosis - Know the difference, think before you refer
-
Jun 16, 2025, 18:24Talha Badar: TKI Selection Based on Mutation Profiles in CML at EHA 2025
-
Jun 16, 2025, 16:24Yelak Biru: Anito-Cel Drives Durable Responses in R/R Multiple Myeloma
-
Jun 15, 2025, 09:32Silent Threat: Underrated Risk of Thrombosis in IBD Outpatients Revealed by New Data - Thrombosis Update
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 18, 2025, 10:30Join "Where Cardiologists and Hematologists Meet" Session Organized by ESC and EHA
-
Jun 18, 2025, 09:01Nihar Desai: A 35 Year Old Man Presents with High Grade Fever...
-
Jun 17, 2025, 18:38Anastasia Conti: The European Hematology Association Congress Was Amazing
-
Jun 17, 2025, 17:07Mark Wildgust: Outstanding Results from the FLAIR Study Presented at EHA25
-
Jun 17, 2025, 15:03Hamayak Sisakian Announces ESC Heart Failure Center Accreditation
Jun 18, 2025, 15:49
Jun 18, 2025, 10:50
Jun 18, 2025, 09:01
Jun 18, 2025, 08:19
Jun 17, 2025, 18:38
Jun 17, 2025, 17:07
Jun 17, 2025, 15:03
Jun 17, 2025, 10:30
Jun 17, 2025, 06:55